(TCRD) |
| 0 (0%) 10-16 01:35 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 17.66 |
| Resistance 1: | 13.95 |
| Pivot price: | 14.12 |
| Support 1: | 7.95 |
| Support 2: | 6.61 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Mon, 04 May 2026
Thymic output in human newborns is shaped by environmental exposures and a common TCRD genetic variant - Rockefeller University Press
Mon, 08 Dec 2025
Comprehensive profiling of smoke-induced T cells in mice implicates clonal γδT17 cells as a hallmark of COPD - Nature
Fri, 01 Mar 2024
γδT cells in oral tissue immune surveillance and pathology - Frontiers
Wed, 30 Aug 2023
Former Olympic coach Paul Stafford takes the reins of new TCRD Swim Team - The Union Democrat
Tue, 05 Apr 2022
IL-17A–producing γδT cells promote muscle regeneration in a microbiota-dependent manner - Rockefeller University Press
Tue, 27 Oct 2020
TCRD basketball registration open - Tifton Gazette
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
